Vivani Medical, Inc. (NASDAQ:VANI) Director Buys $4,999,998.78 in Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams purchased 3,968,253 shares of Vivani Medical stock in a transaction on Friday, November 8th. The stock was bought at an average cost of $1.26 per share, with a total value of $4,999,998.78. Following the completion of the acquisition, the director now owns 4,695,861 shares in the company, valued at approximately $5,916,784.86. This trade represents a 545.38 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this link.

Vivani Medical Stock Performance

NASDAQ:VANI opened at $1.44 on Friday. The company has a market capitalization of $79.57 million, a price-to-earnings ratio of -3.06 and a beta of 3.20. The company has a 50-day moving average of $1.23 and a 200-day moving average of $1.36. Vivani Medical, Inc. has a 52 week low of $0.84 and a 52 week high of $7.80.

Vivani Medical (NASDAQ:VANI) last announced its earnings results on Tuesday, August 13th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.12) by $0.02.

Analyst Ratings Changes

Separately, HC Wainwright started coverage on shares of Vivani Medical in a report on Thursday, November 7th. They issued a “buy” rating and a $3.00 price target for the company.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.